Efficacy and Toxicity Assessment of Different Clinically Used Small Molecular Tyrosine Kinase Inhibitors by Computational Molecular Docking Method
Journal Title: Journal of Metabolomics & Systems Biology - Year 2013, Vol 1, Issue 1
Abstract
Along with the antibody based antiangiogenic (AAG) drugs, several small molecular antiangiogenic (sAAG) drugs are also in clinical practice for the treatment of different cancers. Though population based clinical trials have provided their efficacy; however, comparative efficacies of these drugs at molecular level are not available. The drug-target network is highly important to understand the efficacy and toxicity of drugs in terms of systems biology. In this study, multiply molecular docking between several sAAG drugs and different target receptors are carried out. Our data suggest that though gefitinib is quite potent in targeting different receptors involved in angigiogenesis, but it may impose some serious side effects within physiological system. Our data also suggest that one sAAG drug have some preferential binding affinity to one receptor while have lower binding capacity for other receptor. Hence different sAAG drugs may produce different types of toxicity within the physiological system. For example, lapatinib has highest binding affinity towards NO synthease, while erlotinib has lowest binding affinity to this enzyme. Similarly, sunitinib has highest binding affinity towards beta-2 receptor, while lapatinib has lowest affinity to this receptor. Hence this work provides the rationality of switching between different sAAG drugs during the course of treatment in the control of toxicity by one sAAG drug without discontinuation of therapy and management of toxicity by other drugs.
Authors and Affiliations
Durjoy Majumder
Keywords
Related Articles
- EP ID EP246882
- DOI 10.13188/2329-1583.1000006
- Views 97
- Downloads 0
Extraction of Molecular Features through Exome to Transcriptome Alignment
Integrative Next Generation Sequencing (NGS) DNA and RNA analyses have very recently become feasible, and the published to date studies have discovered critical disease implicated pathways, and diagnostic and therapeutic...
Efficacy and Toxicity Assessment of Different Clinically Used Small Molecular Tyrosine Kinase Inhibitors by Computational Molecular Docking Method
Along with the antibody based antiangiogenic (AAG) drugs, several small molecular antiangiogenic (sAAG) drugs are also in clinical practice for the treatment of different cancers. Though population based clinical trials...
The Hunt for Biomarkers of Autism Spectrum Disorders
Autism spectrum disorders (ASD) are a group of neurodevelopmental disorders in which individuals may experience delayed or impaired language development as well as difficulties in social interactions. Diagnosis is made o...
Profiling and Compositional Analysis of the Exoproteome of Synechocystis Sp. PCC 6803
The exoproteome is one of the important components of the extracellular milieu of the unicellular cyanobacterium Synechocystis sp. PCC 6803, a photosynthetic model organism that is emerging as a potential cell factory fo...
Emerging Applications of Metabolomics in Drug Development
Background: Metabolomics has been increasingly applied in biomedical research and drug efficacy evaluation in the context of rapid advances in analytical instrumentation and bioinformatics. Metabolomics-based discovery w...